DIMETAPP
What it isFirst-generation H1 antagonist; allergic rhinitis and cold symptoms.
Why this oneEffective and inexpensive, widely available in combination products.
What limits itAnticholinergic burden and sedation, so it is poor in the elderly. Impairs driving.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Hay fever symptoms (runny nose, sneezing, itchy nose/throat, itchy watery eyes) | Adults & children ≥12 yr | 20 mL (4 mg) PO Q4H | 20 mL Q4H PRN | 6 doses/24 h |
| Hay fever symptoms | Children 6 to <12 yr | 10 mL (2 mg) PO Q4H | 10 mL Q4H PRN | 6 doses/24 h |
| Hay fever symptoms | Children <6 yr | Do not use | Do not use | Do not use |
Renal Undefined
Hepatic Undefined
Max 6 doses per 24 hours
Pregnancy If pregnant or breast-feeding, ask a health professional before use.
Lactation If pregnant or breast-feeding, ask a health professional before use.
NO BOXED WARNINGS
Principal riskAnticholinergic burden and sedation

Open Brompheniramine in the interactive console ↗
